Opinion
Korea Joongang Daily on MSN1dOpinion
A wake-up call for our drug authorities
The drug is a novel gene therapy to treat knee OA. Kolon developed it at a cost of more than 200 billion won ($143 million) since 1999. After clinical trials in Korea and the United States, the drug ...
Lee Woong-yeol, honorary chairman of Kolon, 'Invossa Incident' is not guilty after more than four years.
Anchor] Do you remember the so-called 'Invossa incident' that caused a stir in society five years ago?It was released as the ...
Invossa Victims "We will prove Kolon's negligence and take responsibility for compensation."
Even if Kolon Group Chairman Lee Woong-yeol and others were acquitted in the first trial, the victims of the Invossa incident ...
중앙일보1d
A wake-up call for our drug authorities (KOR)
Brace for the onslaught of Chinese EVs and Trump’s tariff (KOR) Kolon Industries flaunts quadrupled earnings on year in second quarter ...